Popular Trials
Behavioral Intervention
Noise Correlations Study for Dyslexia
"This trial aims to study how the brain processes information using noisy neurons. The researchers believe that noise correlations between neurons may actually help reduce the complexity of learning tasks. They plan to test this hypothesis using computational
Behavioral Intervention
Phonemic Segmentation for Early Literacy
"This trial will investigate whether practicing specific mouth movements while learning letters and sounds helps improve reading skills in young children more than just general mouth exercises or traditional letter/sound training."
Behavioural Intervention
Reading Program for Language Developmental Disorders
This trial aims to study the effects of a caregiver-led reading program called Sit Together and Read (STAR) on children aged 4 to 5 with developmental language disorder. The study will assess how STAR
Popular Filters
Trials With No Placebo
Behavioural Intervention
Let's Know! Intervention for Childhood Language Disorders
This trial will test the efficacy of Let's Know!, a small-group, language focused comprehension intervention, on children's lower- and higher-level language skills and comprehension skills in the short- and long-term.
Behavioural Intervention
Transcranial Magnetic Stimulation for Rolandic Epilepsy
This trial will test if treating IEDs in children with epilepsy can improve language skills by using transcranial magnetic stimulation (TMS) to stimulate the brain region where the IEDs originate.
Frequently Asked Questions
Introduction to dyslexia
What are the top hospitals conducting dyslexia research?
In the realm of dyslexia research, several institutions have emerged as pioneers in understanding and treating this neurodevelopmental condition. One such institution is Vanderbilt University in Nashville, where researchers are currently conducting two active clinical trials focused on dyslexia. Since their first recorded trial in 2016, Vanderbilt has made significant strides in expanding our knowledge of this condition. Moving northward to Edmonton, Canada, the Department of Communication Sciences and Disorders at the University of Alberta is also dedicating resources to dyslexia studies. With one ongoing trial and a single previous trial since their initiation into dyslexia research in 2023, they are making valuable contributions to the field.
Interestingly enough, not all clinical trials for dyslexia take place within traditional hospital settings. The Excelsior Springs School District located in Excelsior Springs is actively involved in a dyslexia study, showcasing that research efforts extend beyond medical centers alone.
Furthermore,Vanderbilt University Medical Center continues its commitment to understanding and addressing dyslexia with an ongoing clinical trial. Having initiated their first recorded trial back in 2022, they join other distinguished institutions aiming to improve our understanding and treatment options for individuals with this condition.
Heading up north again to Montreal's McGill University offers another perspective on tackling dyslexia through research initiatives. Their involvement includes one ongoing clinical trial along with two previously conducted trials dating back as far as 2008—a testament to long-standing dedication within their academic community.
These collaborative endeavors among top educational and medical institutions underscore society's collective determination towards unraveling the complexities associated with dyslexic conditions while striving for more inclusive approaches toward learning disabilities overall
Which are the best cities for dyslexia clinical trials?
When it comes to dyslexia clinical trials, several cities have emerged as leaders in research and development. Nashville, Tennessee stands out with 3 active trials focused on interventions such as RLN and CCN real non-invasive brain stimulation, Reading Tutoring Intervention, and NF1: Lovastatin + reading tutoring. Edmonton in Alberta, Excelsior Springs in Missouri, and Montreal in Quebec each have 1 active trial exploring different approaches like Condition study design or Set For Variability intervention. Additionally, Boston in Massachusetts is also conducting a single trial known as Let's Know! small-group or TierL 2 Intervention. These cities offer valuable opportunities for individuals with dyslexia to participate in cutting-edge clinical trials that may lead to improved understanding and treatment of the condition.
Which are the top treatments for dyslexia being explored in clinical trials?
Exciting advancements are taking place in the realm of dyslexia research, with two promising treatments currently under exploration in clinical trials. The RLN and CCN (real non-invasive brain stimulation) intervention is showing great potential, with one active trial dedicated to dyslexia. Another treatment called Set For Variability is also being investigated, demonstrating promise through its own active trial. Both interventions have recently entered the scene, listed for the first time in 2022. These developments offer hope for individuals struggling with dyslexia and bring us closer to finding effective solutions for this learning disorder.
What are the most recent clinical trials for dyslexia?
The field of dyslexia research is constantly evolving, with recent clinical trials offering promising insights into the condition. One such trial focuses on a new treatment for dyslexia, with participants undergoing Phase 4 testing to assess its effectiveness. Another study investigates the combined use of Lovastatin and reading tutoring in individuals with dyslexia, aiming to uncover potential therapeutic benefits. These trials represent important steps towards better understanding and managing dyslexia, providing hope for improved outcomes in affected individuals.
What dyslexia clinical trials were recently completed?
Recently, several clinical trials focused on dyslexia have reached completion, offering valuable insights into potential treatments and interventions for this common learning disorder. While specific details of these trials may vary, their collective goal is to enhance our understanding of dyslexia and improve support for individuals affected by it. These recent completed studies represent significant steps forward in the field of dyslexia research and highlight ongoing efforts to address the challenges faced by those with this condition.